PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Coeptis Therapeutics Holdings, Inc.
Filed: March 18, 2022
Period of Report: March 18, 2022
Accession Number: 0001213900-22-013645

View Document ↗ View on SEC.gov ↗